Antonio Cuneo
Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Italy

Full Professor of Hematology University of Ferrara, Director of Hematology Section – Azienda Ospedaliero Universitaria Arcispedale S. Anna Ferrara
Work Experience
October 1988- March 1989: Visiting Scientist At Centre For Human Genetics; K.U.L. Leuven, Belgium During Studies For PH.D. In Experimental Hematology, Then Frequent Short Stays Until 1995.
1990: “Appointed as full-time Researcher” at the Section of Hematology, University of Ferrara, with an established role in providing health care in the Hematology Unit of the Azienda Ospedaliero Universitaria in Ferrara –
2001: Associate Professor of Hematology , University of Ferrara
2005: Full Professor of Hematology, University of Ferrara
2006: Director of Hematology Section – S. ANNA University Hospital, Ferrara
2011-2015: Coordinator Ph.D. Programme in Molecular Medicine and Pharmacology, University of Ferrara
2012-2017: Director of the Department of Specialistic Medicine at the University Hospital in Ferrara, Italy
February 2019: Full professor of Hematology University of Ferrara (50% Full Time Equivalent) and University of Parma (50% FTE)
Organisational Skills & Competences
- Member of the Italian Society of Hematology and of Italian Society of Experimental Hematology
- Member of Board of the Italian Society of Experimental Hematology from 1997 till 2002
- President of the Italian Society of Experimental Hematology for biennium 2007-2008
- President of Interfaculty Specialist Degree Course of Medical-Pharmaceutical Biotechnologies for biennium 2006-2007
- Coordinator of Ph.D. school of Pharmacology and Molecular Oncology
- January 2011- December 2015
- October 2015-October 2019: President of the “College of the full professors of Hematology of the Italian universities”
- August 2018: President of the Scientific Committee of the GIMEMA foundation
- May 2021: Chairman of the national working party of the GIMEMA group on ‘chronic lymphocytic leukemia and chronic lymphoproliferative disorders’